Sensus Healthcare (SRTS) Releases Q3 2026 Earnings: Revenue Declines, Gross Profit Improves

Sensus Healthcare, Inc. (NASDAQ: SRTS) reported third-quarter 2026 revenue of $6.0 million, down 12.9% from a year earlier and below the $6.7 million analyst estimate. Gross profit rose 21.2% to $3.3 million, showing improved margin performance even as sales declined.

The company posted an operating loss of $1.6 million and a net loss attributable to common shareholders of $1.4 million, or $(0.09) per diluted share. That was an improvement from the prior-year per-share loss, though results remained negative overall.

Cash used in operating activities widened to $3.1 million, while capital spending was minimal at $8,000. Sensus ended the quarter with $12.9 million in cash and cash equivalents, and total liabilities fell to $5.1 million.

Note: This financials data is sourced from a third-party provider and has not been independently verified by Investivoq.

Sensus Healthcare, Inc. Insider Trading Activity

Sensus Healthcare, Inc. insiders have traded $SRTS stock on the open market 8 times in the past 6 months. Of those trades, 8 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $SRTS stock by insiders over the last 6 months:

• ERIC SACHETTA has made 7 purchases buying 151,171 shares for an estimated $503,052 and 0 sales.
• JOSEPH C SARDANO (CHIEF EXECUTIVE OFFICER) purchased 20,000 shares for an estimated $60,486

To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

Sensus Healthcare, Inc. Hedge Fund Activity

We have seen 14 institutional investors add shares of Sensus Healthcare, Inc. stock to their portfolio, and 17 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MEROS INVESTMENT MANAGEMENT, LP removed 152,418 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $460,302
• NORTHERN TRUST CORP removed 40,006 shares (-58.7%) from their portfolio in Q2 2026, for an estimated $120,818
• MINDSET WEALTH MANAGEMENT, LLC added 33,900 shares (+65.1%) to their portfolio in Q3 2026, for an estimated $101,361
• GREENLINE WEALTH MANAGEMENT LLC added 20,000 shares (+15.5%) to their portfolio in Q3 2026, for an estimated $59,800
• IMC-CHICAGO, LLC added 17,742 shares (+inf%) to their portfolio in Q3 2026, for an estimated $53,048
• EP WEALTH ADVISORS, LLC added 16,065 shares (+inf%) to their portfolio in Q2 2026, for an estimated $48,516
• ACADIAN ASSET MANAGEMENT LLC removed 15,273 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $46,124

To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.